DexCom (NASDAQ: DXCM)
DexCom Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DexCom Company Info
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
News & Analysis
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
2 Excellent Healthcare Stocks to Hold Through the Next Decade
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
This medical device company is down but not out.
Why DexCom Stock Flopped on Friday
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.
DexCom Meets Q3 Guidance as Growth Slows
DexCom met revenue expectations amid slower growth and profitability challenges.
Where Will DexCom Be in 5 Years?
Recent developments might have scared away some investors, but patience could pay off.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.